Philip C. Hoffmann

1.1k total citations
33 papers, 870 citations indexed

About

Philip C. Hoffmann is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Philip C. Hoffmann has authored 33 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cellular and Molecular Neuroscience, 15 papers in Molecular Biology and 6 papers in Physiology. Recurrent topics in Philip C. Hoffmann's work include Neuroscience and Neuropharmacology Research (14 papers), Nerve injury and regeneration (6 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). Philip C. Hoffmann is often cited by papers focused on Neuroscience and Neuropharmacology Research (14 papers), Nerve injury and regeneration (6 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). Philip C. Hoffmann collaborates with scholars based in United States, Russia and Germany. Philip C. Hoffmann's co-authors include Alfred Heller, Bruce H. Wainer, Lisa Won, Paul J. Kontur, Beatrice B. Garber, Lisa M. Hemmendinger, Perry V. Halushka, Lloyd J. Roth, David N. Hammond and Aaron P. Fox and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Comparative Neurology.

In The Last Decade

Philip C. Hoffmann

33 papers receiving 816 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip C. Hoffmann United States 16 520 368 142 128 93 33 870
Gilbert Clincke Belgium 17 389 0.7× 317 0.9× 68 0.5× 105 0.8× 79 0.8× 41 873
B. B. Mršulja Romania 16 546 1.1× 460 1.3× 84 0.6× 287 2.2× 283 3.0× 57 1.3k
M Bertolino United States 14 816 1.6× 785 2.1× 67 0.5× 80 0.6× 147 1.6× 15 1.2k
Ranbir K. Bhatnagar United States 15 375 0.7× 193 0.5× 46 0.3× 96 0.8× 90 1.0× 31 679
Wolfgang Lo ̈scher Germany 11 540 1.0× 348 0.9× 96 0.7× 80 0.6× 62 0.7× 11 1.1k
Stuart E. Smith United Kingdom 13 705 1.4× 429 1.2× 47 0.3× 113 0.9× 69 0.7× 18 1.0k
K. Richter United States 12 256 0.5× 352 1.0× 145 1.0× 84 0.7× 320 3.4× 21 924
Philip F. Morgan United States 15 402 0.8× 447 1.2× 61 0.4× 95 0.7× 75 0.8× 25 853
F. F. Földes United States 17 368 0.7× 492 1.3× 47 0.3× 54 0.4× 132 1.4× 81 1.1k
Richard C. Wiggins United States 19 237 0.5× 321 0.9× 225 1.6× 66 0.5× 299 3.2× 41 1.1k

Countries citing papers authored by Philip C. Hoffmann

Since Specialization
Citations

This map shows the geographic impact of Philip C. Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip C. Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip C. Hoffmann more than expected).

Fields of papers citing papers by Philip C. Hoffmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip C. Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip C. Hoffmann. The network helps show where Philip C. Hoffmann may publish in the future.

Co-authorship network of co-authors of Philip C. Hoffmann

This figure shows the co-authorship network connecting the top 25 collaborators of Philip C. Hoffmann. A scholar is included among the top collaborators of Philip C. Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip C. Hoffmann. Philip C. Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heller, Alfred, Lisa Won, Bárbara Heller, & Philip C. Hoffmann. (1995). EXAMINATION OF DEVELOPMENTAL NEUROTOXICITY BY THE USE OF TISSUE CULTURE MODEL SYSTEMS. Clinical and Experimental Pharmacology and Physiology. 22(5). 375–378. 1 indexed citations
2.
Won, Lisa, et al.. (1992). Acute and persistent effects of methamphetamine on developing monoaminergic neurons in reaggregate tissue culture. Brain Research. 575(1). 6–12. 12 indexed citations
3.
Kontur, Paul J., Lisa Won, Philip C. Hoffmann, & Alfred Heller. (1991). Survival of developing dopaminergic neurons in reaggregate tissue culture following treatment with methamphetamine. Neuroscience Letters. 129(2). 254–258. 15 indexed citations
4.
Won, Lisa, Paul J. Kontur, David N. Hammond, et al.. (1991). Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion. Brain Research. 552(1). 67–76. 190 indexed citations
5.
Won, Lisa, Alfred Heller, & Philip C. Hoffmann. (1989). Selective association of dopamine axons with their striatal target cells in vitro. Developmental Brain Research. 47(1). 93–100. 12 indexed citations
6.
Heller, Alfred, et al.. (1989). The effects of nerve growth factor on the development of septal cholinergic neurons in reaggregate cell cultures. Neuroscience. 29(1). 209–223. 24 indexed citations
7.
Won, Lisa, Steven D. Price, Bruce H. Wainer, et al.. (1989). Correlated light and electron microscopic study of dopaminergic neurons and their synaptic junctions with DARPP‐32‐containing cells in three‐dimensional reaggregate tissue culture. The Journal of Comparative Neurology. 289(1). 165–177. 18 indexed citations
8.
9.
Kontur, Paul J., Philip C. Hoffmann, & Alfred Heller. (1986). Neurotoxicity of dopaminergic agents assessed in reaggregate tissue culture. The Society for Neuroscience Abstracts. 12(1). 92. 1 indexed citations
10.
Shalaby, Ismail A., Philip C. Hoffmann, & Alfred Heller. (1984). Release of dopamine from mesencephalic neurons in aggregate cultures: influence of target and non-target cells. Brain Research. 307(1-2). 347–350. 9 indexed citations
11.
Horwitz, Joel, Alfred Heller, & Philip C. Hoffmann. (1982). The effect of development of thermoregulatory function on the biochemical assessment of the ontogeny of neonatal dopaminergic neuronal activity. Brain Research. 235(2). 245–252. 15 indexed citations
12.
Hemmendinger, Lisa M., Beatrice B. Garber, Philip C. Hoffmann, & Alfred Heller. (1981). Selective association of embryonic murine mesencephalic dopamine neurons in vitro. Brain Research. 222(2). 417–422. 24 indexed citations
13.
Dinerstein, Robert J., J L Vannice, Richard C. Henderson, et al.. (1979). Histofluorescence Techniques Provide Evidence for Dopamine-Containing Neuronal Elements in Canine Kidney. Science. 205(4405). 497–499. 114 indexed citations
14.
Swift, Robert M., Philip C. Hoffmann, & Alfred Heller. (1978). Activity-dependent changes in substantia nigra γ-aminobutyric acid. Brain Research. 156(1). 181–186. 6 indexed citations
15.
Hoffmann, Philip C., et al.. (1975). UBIQUINONE REDOX STATUS IN BRAIN IN VITRO. Journal of Neurochemistry. 24(5). 1023–1028. 5 indexed citations
16.
Hoffmann, Philip C., et al.. (1973). The Effect of Changes in Functional Activity on Ubiquinone Redox Status in Isolated Atria. European Journal of Biochemistry. 37(2). 259–269. 8 indexed citations
17.
Siess, M., et al.. (1970). Inhibition of the mitochondrial respiratory chain in isolated atria—A comparision of rotenone and amytal. Biochemical Pharmacology. 19(1). 197–207. 8 indexed citations
18.
Brown, David A., Philip C. Hoffmann, & Lloyd J. Roth. (1969). 3H‐Nicotine in cat superior cervical and nodose ganglia after close‐arterial injection in vivo. British Journal of Pharmacology. 35(3). 406–417. 15 indexed citations
19.
Halushka, Perry V. & Philip C. Hoffmann. (1968). Does tetrahydropapaveroline contribute to the cardiovascular actions of dopamine?. Biochemical Pharmacology. 17(9). 1873–1880. 20 indexed citations
20.
Halushka, Perry V. & Philip C. Hoffmann. (1968). Distribution and metabolism of dopamine in guinea-pigs. Journal of Pharmacy and Pharmacology. 20(12). 943–946. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gilbert Clincke Breakdown of academic impact, for papers by B. B. Mršulja Breakdown of academic impact, for papers by M Bertolino Breakdown of academic impact, for papers by Ranbir K. Bhatnagar Breakdown of academic impact, for papers by Wolfgang Lo ̈scher Breakdown of academic impact, for papers by Stuart E. Smith Breakdown of academic impact, for papers by K. Richter Breakdown of academic impact, for papers by Philip F. Morgan Breakdown of academic impact, for papers by F. F. Földes Breakdown of academic impact, for papers by Richard C. Wiggins
Rankless by CCL
2026